rs3750123

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_198428.3(BBS9):​c.-407C>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 152,934 control chromosomes in the GnomAD database, including 2,157 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.16 ( 2141 hom., cov: 32)
Exomes 𝑓: 0.19 ( 16 hom. )

Consequence

BBS9
NM_198428.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0600

Publications

4 publications found
Variant links:
Genes affected
BBS9 (HGNC:30000): (Bardet-Biedl syndrome 9) This gene is downregulated by parathyroid hormone in osteoblastic cells, and therefore is thought to be involved in parathyroid hormone action in bones. The exact function of this gene has not yet been determined. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2017]
BBS9 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • BBS9-related ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-33129646-C-G is Benign according to our data. Variant chr7-33129646-C-G is described in ClinVar as Benign. ClinVar VariationId is 360051.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.204 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_198428.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS9
NM_198428.3
MANE Select
c.-407C>G
5_prime_UTR_premature_start_codon_gain
Exon 1 of 23NP_940820.1Q3SYG4-1
BBS9
NM_198428.3
MANE Select
c.-407C>G
5_prime_UTR
Exon 1 of 23NP_940820.1Q3SYG4-1
BBS9
NM_001348041.4
c.-407C>G
5_prime_UTR_premature_start_codon_gain
Exon 1 of 23NP_001334970.1A0A5F9ZH14

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS9
ENST00000242067.11
TSL:1 MANE Select
c.-407C>G
5_prime_UTR_premature_start_codon_gain
Exon 1 of 23ENSP00000242067.6Q3SYG4-1
BBS9
ENST00000242067.11
TSL:1 MANE Select
c.-407C>G
5_prime_UTR
Exon 1 of 23ENSP00000242067.6Q3SYG4-1
BBS9
ENST00000433714.5
TSL:1
n.-407C>G
5_prime_UTR_premature_start_codon_gain
Exon 1 of 24ENSP00000412159.1F8WCG5

Frequencies

GnomAD3 genomes
AF:
0.162
AC:
24622
AN:
151976
Hom.:
2136
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0975
Gnomad AMI
AF:
0.0846
Gnomad AMR
AF:
0.179
Gnomad ASJ
AF:
0.182
Gnomad EAS
AF:
0.154
Gnomad SAS
AF:
0.216
Gnomad FIN
AF:
0.208
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.186
Gnomad OTH
AF:
0.179
GnomAD4 exome
AF:
0.190
AC:
160
AN:
840
Hom.:
16
Cov.:
0
AF XY:
0.195
AC XY:
108
AN XY:
554
show subpopulations
African (AFR)
AF:
0.188
AC:
6
AN:
32
American (AMR)
AF:
0.167
AC:
1
AN:
6
Ashkenazi Jewish (ASJ)
AF:
0.300
AC:
3
AN:
10
East Asian (EAS)
AF:
0.192
AC:
5
AN:
26
South Asian (SAS)
AF:
0.286
AC:
20
AN:
70
European-Finnish (FIN)
AF:
0.192
AC:
5
AN:
26
Middle Eastern (MID)
AF:
0.250
AC:
2
AN:
8
European-Non Finnish (NFE)
AF:
0.180
AC:
111
AN:
616
Other (OTH)
AF:
0.152
AC:
7
AN:
46
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.162
AC:
24657
AN:
152094
Hom.:
2141
Cov.:
32
AF XY:
0.164
AC XY:
12173
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0981
AC:
4072
AN:
41520
American (AMR)
AF:
0.179
AC:
2735
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.182
AC:
631
AN:
3470
East Asian (EAS)
AF:
0.154
AC:
792
AN:
5150
South Asian (SAS)
AF:
0.215
AC:
1035
AN:
4814
European-Finnish (FIN)
AF:
0.208
AC:
2201
AN:
10574
Middle Eastern (MID)
AF:
0.194
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
0.186
AC:
12675
AN:
67982
Other (OTH)
AF:
0.181
AC:
382
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1033
2066
3099
4132
5165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.176
Hom.:
307
Bravo
AF:
0.156
Asia WGS
AF:
0.201
AC:
698
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Bardet-Biedl syndrome 9 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.9
DANN
Benign
0.62
PhyloP100
-0.060
PromoterAI
0.10
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3750123; hg19: chr7-33169258; API